Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.006 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.006 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.007 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |